Viewing data from:

LINCOMYCIN HYDROCHLORIDE

ANDA

LINCOMYCIN HYDROCHLORIDE | A201746 | XGEN PHARMACEUTICALS DJB INC

1 strength0 unique patents0 unique exclusivities

Reference Listed Drug: LINCOCIN(TE code: AP)

API Supply Chain6 active DMFs6 inactive

6 active API suppliers hold Drug Master Files for this ingredient.

PHARMACIA AND UPJOHN CO LLC WHOLLY OWNED SUB OF PFIZER INCLINCOMYCIN HYDROCHLORIDE USP

DMF 132921998

JIANGXI GUOYAO PHARMACEUTICAL LLCLINCOMYCIN HYDROCHLORIDE

DMF 137531998

NORTH CHINA PHARMACEUTICAL GROUP HUALUAN CO LTDLINCOMYCIN HYDROCHLORIDE

DMF 171422004

XINYU PHARMACEUTICAL CO LTDLINCOMYCIN HYDROCHLORIDE USP

DMF 190562005

NANYANG PUKANG PHARMACEUTICAL CO LTDLINCOMYCIN HYDROCHLORIDE

DMF 266102012

TOPFOND PHARMACEUTICAL CO LTDLINCOMYCIN HYDROCHLORIDE

DMF 371242022

CIBRANInactiveLINCOMYCIN HYDROCHLORIDE

DMF 137001998

SUZHOU NUMBER 4 PHARMACEUTICAL FACTORYInactiveLINCOMYCIN HYDROCHLORIDE

DMF 137571998

ABBOTT INDUSTRIES INCInactiveLINCOMYCIN HYDROCHLORIDE MONOHYDRATE BULK

DMF 147521998

NINGXIA TAIYICIN BIOTECH CO LTDInactiveLINCOMYCIN HYDROCHLORIDE

DMF 314622017

LIVZON GROUP NINGXIA PHARMACEUTICAL CO LTDInactiveLINCOMYCIN HYDROCHLORIDE USP

DMF 323222017

NINGXIA TAIYICIN BIOTECH CO LTDInactiveLINCOMYCIN HYDROCHLORIDE

DMF 362502021

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Approval Letters

1 letter from Drugs@FDA

Date	Submission	Document
Jun 10, 2015	ORIG -1	View Letter (PDF)

Source: Drugs@FDA application documents.

Products (1)

#001 — EQ 300MG BASE/ML

0 patents0 exclusivities▴

INJECTABLE;INJECTION | Approved: Jun 4, 2015

No patent or exclusivity listings for this strength.